EP2034956

ALTERGON S.A.
Application Number
EP07729534A
Filing Date
May 25, 2007
Status
Patent Maintained As Amended
May 26, 2023
Grant Date
Jun 28, 2023
External Links
Slate, Register

Biblio Summary

The patent EP2034956B2 was granted on Jun 28, 2023 by Altergon S.A. The patent is currently Patent Maintained As Amended.

The table below shows 1 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

STREHLKE, INGO KURTDec 21, 2018 N.A.

The table below shows the patents of Altergon S.A. that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3056187Single-Dose Pharmaceutical Preparation Of Thyroid Hormones T3 And/Or T4Aug 30, 20231
EP3528847High-Stability Packaged Solutions Of T4 Thyroid HormoneJul 22, 20201